ロード中...
Effectiveness and tolerability of second-line treatment with vildagliptin versus other oral drugs for type 2 diabetes in a real-world setting in the Middle East: results from the EDGE study
BACKGROUND: Type 2 diabetes mellitus (T2DM) is a chronic progressive disease that requires treatment intensification with antihyperglycemic agents due to progressive deterioration of β-cell function. A large observational study of 45,868 patients with T2DM across 27 countries (EDGE) assessed the eff...
保存先:
| 出版年: | Vasc Health Risk Manag |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4348128/ https://ncbi.nlm.nih.gov/pubmed/25750538 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S73703 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|